Texas Department of State Health Services data showed less than 50 HMPV-positive cases each week in December across the state ...

Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...

State and federal data show high levels of respiratory illnesses. Here's what to know about the illnesses circulating this ...

In China, reports of HMPV infections have indeed been rising in recent weeks in the more northerly regions. But so have ...

For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.

Hospital leaders expect case volume of flu, the common cold, and respiratory syncytial virus, RSV, to keep climbing. Statewide respiratory illnesses are labeled as “very high,” according to the U.S.

A recent increase in cases of the human metapneumovirus (hMPV) in China has been misrepresented on social media as evidence ...

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

An 80-year-old man tested positive for human metapneumovirus (HMPV) infection in Ahmedabad city of Gujarat on Thursday, ...

The elderly man has been admitted to the hospital on Wednesday and his samples tested positive for HMPV on Thursday. The man ...

A surge in respiratory infections in China has put in focus a little known virus—the Human Metapneumovirus (HMPV)—largely ...

Cases of human metapneumovirus, or HMPV, a contagious virus that can lead to respiratory disease, is reportedly spiking in northern China. Infectious disease experts say risk to the U.S. is low.